July 21, 2024
You are here:  Home  >  Banking & Finance  >  Tri-County Public Companies  >  Earnings  >  Current Article

MannKind excites investors, analysts after huge bump in sales


MannKind shares rose nearly 20% on Aug. 8, one day after the company highlighted its earnings results for the second quarter of 2022. MannKind, a biotechnology company that develops treatments for diabetes and pulmonary arterial hypertension, delivered revenue worth $49.6 million in the second quarter of 2023, up 157% from the same quarter a year…


    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.